<DOC>
	<DOC>NCT00397631</DOC>
	<brief_summary>A clinical study to evaluate the safety and efficacy of the initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes mellitus not on treatment with insulin or oral antihyperglycemic therapy.</brief_summary>
	<brief_title>Initial Combination With Pioglitazone Study (0431-064)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>General Patients â‰¥18 years old with Type 2 Diabetes Mellitus (a specific type of diabetes) General Patient has a history of type 1 diabetes mellitus or history of ketoacidosis Patient was on antihyperglycemic agent therapy (oral or insulin) within the prior 4 months Patient was on &gt;4 weeks (cumulatively) of antihyperglycemic therapy (oral or insulin) over the prior 2 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>